Biocon has entered the US eye drug market with the commercial launch of Yesafili, its aflibercept biosimilar to Eylea.
Retatrutide Early Access has started for a limited group of patients before its expected FDA approval. Eli Lilly has launched an expanded access program for eligible adults with severe obesity.
Surgical drug innovation takes center stage as Dr. Reddy’s Laboratories expands its US portfolio with the launch of Sugammadex injection
The dental implant safety framework is under consideration by the Central government as concerns grow over the quality, regulation, and long-term safety of dental implants used across India.
Drug launches, pharma policy, and healthcare investment trends continue to reshape the global and Indian pharmaceutical landscape
Bike ambulance services will gain regulatory clarity as India drafts new rules to strengthen emergency response systems, the proposal also introduces standards to ensure construction, safety, and functional compliance
Moderna has beaten Wall Street revenue estimates just days before a major US regulatory decision. The quarterly revenue surprise comes as the company prepares for the FDA's verdict on its flu vaccine.
11,000 Travellers Screened as India Tightens Ebola Watch has put health authorities on alert across the country.
Cancer drug development drives Glenmark’s next phase of global expansion, the company targets USD 600 million revenue from new oncology launches
Childhood leukaemia remains a major health concern across the region. A new study shows India accounts for nearly 70% of South Asia's childhood leukaemia cases.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")